Please login to the form below

Not currently logged in
Email:
Password:

tecemotide

This page shows the latest tecemotide news and features for those working in and with pharma, biotech and healthcare.

Merck makes $17bn play for Sigma-Aldrich

Merck makes $17bn play for Sigma-Aldrich

had something of a new product drought in recent years, compounded by late-stage failures including recent casualty tecemotide.

Latest news

  • Merck Serono pulls development of lung cancer prospect Merck Serono pulls development of lung cancer prospect

    Merck Serono pulls development of lung cancer prospect. Ditches tecemotide immunotherapy to focus on anti-PD1. ... The phase I/II trial, known as EMR 63325-009, compared tecemotide to placebo in patients on concurrent or sequential chemoradiotherapy.

  • Developing therapeutic cancer vaccines Developing therapeutic cancer vaccines

    Tecemotide (Oncothyreon, Merck KGaA, Merck Serono) consists of mucin-1 (MUC-1), a cell surface glycoprotein that is over-expressed and structurally different in approximately 90 per cent of solid tumours ... Tecemotide is in global phase III development

  • Merck Serono puts faith in lung cancer candidate Merck Serono puts faith in lung cancer candidate

    Merck Serono puts faith in lung cancer candidate. Continues tecemotide development despite underwhelming phase III results. ... Merck Serono has decided to continue development of its tecemotide immunotherapy for non-small cell lung cancer (NSCLC)

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during August 2014 Pharma deals during August 2014

    Oncothyreon's clinical stage pipeline includes the immunotherapy candidates tecemotide (phase III - Stage III non-small cell lung cancer) and ONT-10 (phase 1 - solid tumour treatment), and the only

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics